Back

Novel platelet-to-lymphocyte and glucose-to-lymphocyte ratios as prognostic markers in acute coronary syndrome

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Biomarkers in acute coronary syndromes (6) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Panagiotis Stachteas

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

5 More presentations in this session

Presentation thumbnail
Relation of high sensitivity c-reactive protein and low-density lipoprotein-cholesterol level to coronary artery plaque morphology and plaque rupture in patients with acute coronary syndromes
Doctor J. Yu (Frankfurt Am Main, DE)
Abstract Slides Video
Presentation thumbnail
High-sensitivity troponin I peak in MINOCA: a useful tool in the right clinical context?
Doctor C. Lagoas Pohle (Setubal, PT)
Abstract Slides Video
Presentation thumbnail
Oxidized phospholipids (OxPLs) dynamics following acute myocardial infarction (MI): effects of PCSK9 inhibition with evolocumab
Associate Professor T. Leucker (Baltimore, US)
Abstract Slides Video
Presentation thumbnail
Leptin and adiponectin independently predict a first-ever myocardial infarction with a sex difference.
Doctor N. Hansen (Umea, SE)
Abstract Slides Video
Presentation thumbnail
The neuropetide secretoneurin in STEMI patients: association with major adverse cardiovascular events
Doctor A. Kaser (Innsbruck, AT) Doctor F. Oberhollenzer (Innsbruck, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Biomarkers in acute coronary syndromes (6)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Microalbuminuria as an independent predictor of long-term mortality in diabetic and non-diabetic patients with acute coronary syndromes
thumbnail
Congress Session
Risk factors, predictive models, and clinical outcomes in acute coronary conditions
thumbnail
Congress Session
Determinants of long-term outcome following acute myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources